1981
DOI: 10.1097/00006254-198107000-00017
|View full text |Cite
|
Sign up to set email alerts
|

Pregnancy in Inflammatory Bowel Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1983
1983
2022
2022

Publication Types

Select...
2
2
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…They have no demonstrated effect on prematurity, spontaneous abortion or stillbirth [9] . Adrenal suppression in the fetus due to maternal use has hitherto been described infrequently [10][11][12][13][14] .…”
Section: Introductionmentioning
confidence: 96%
“…They have no demonstrated effect on prematurity, spontaneous abortion or stillbirth [9] . Adrenal suppression in the fetus due to maternal use has hitherto been described infrequently [10][11][12][13][14] .…”
Section: Introductionmentioning
confidence: 96%
“…Sulphasalazine also crosses the placenta (89,90) and could theoretically displace conjugated bilirubin from binding sites on albumin and thus predispose to kernicterus. However, two large retrospective studies of pregnancy in colitis, which include altogether over 200 pregnancies in mothers receiving sulphasalazine and 190 in mothers receiving corticosteroids, have shown a reassuring and convincing lack of any complications resulting from drug therapy in pregnancy (91,92). Sulphasalazine therapy should therefore be continued throughout pregnancy unless previous attacks of colitis have been very mild and distal while any acute attack of colitis occurring during pregnancy should be treated promptly with corticosteroids in the same way as in a nonpregnant patient.…”
Section: Treatment In Pregnancymentioning
confidence: 99%
“…Corticosteroids and sulphasalazine seem to be very safe in pregnancy (91,92) so any attacks of Crohn's disease occurring in pregnancy should be treated conventionally using these drugs. It is, of course, very important that the obstetrician and neonatal paediatrician are aware of the mother's corticosteroid treatment.…”
Section: Treatment In Pregnancymentioning
confidence: 99%